RTX Corp: Form 10-Q for the period ended Jun 30, 2020
Filed with the SEC on Jul 29, 2020 and accepted by EDGAR at Jul 28, 2020, 19:50 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-04-01 to 2020-06-30 | $14.06bn | us-gaap:Revenues |
| Revenue | 6 months2020-01-01 to 2020-06-30 | $25.42bn | us-gaap:Revenues |
| Research and development | 3 months2020-04-01 to 2020-06-30 | $695.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2020-01-01 to 2020-06-30 | $1.23bn | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2020-04-01 to 2020-06-30 | $1.81bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2020-01-01 to 2020-06-30 | $2.79bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2020-04-01 to 2020-06-30 | −$3.76bn | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2020-01-01 to 2020-06-30 | −$2.46bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2020-04-01 to 2020-06-30 | $335.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2020-01-01 to 2020-06-30 | $667.0m | us-gaap:InterestExpense |
| Income tax | 3 months2020-04-01 to 2020-06-30 | −$38.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2020-01-01 to 2020-06-30 | $601.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-04-01 to 2020-06-30 | −$3.83bn | us-gaap:NetIncomeLoss |
| Net income | 6 months2020-01-01 to 2020-06-30 | −$3.92bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2020-04-01 to 2020-06-30 | −$2.55 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2020-01-01 to 2020-06-30 | −$3.20 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2020-04-01 to 2020-06-30 | −$2.55 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2020-01-01 to 2020-06-30 | −$3.20 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2020-04-01 to 2020-06-30 | 1,501,300,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2020-01-01 to 2020-06-30 | 1,225,400,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2020-01-01 to 2020-06-30 | $1.34bn | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 6 months2020-01-01 to 2020-06-30 | $783.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 6 months2020-01-01 to 2020-06-30 | $1.34bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2020-01-01 to 2020-06-30 | $47.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2020-06-30 | $6.97bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-06-30 | $42.27bn | us-gaap:AssetsCurrent |
| Total assets | At period end2020-06-30 | $161.52bn | us-gaap:Assets |
| Current liabilities | At period end2020-06-30 | $35.29bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-06-30 | $92.59bn | us-gaap:Liabilities |
| Short-term borrowings | At period end2020-06-30 | $243.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2020-06-30 | $67.22bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000101829-20-000055. Last ingested by Listed: Nov 3, 2026, 21:25 ET. Listed shows no prices and gives no investment advice.